2021
DOI: 10.1016/j.giant.2020.100040
|View full text |Cite
|
Sign up to set email alerts
|

Doxorubicin@ PEPylated interferon-polydisulfide: A multi-responsive nanoparticle for enhanced chemo–protein combination therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 43 publications
0
15
1
Order By: Relevance
“…Synthetic polypeptides have been used for protein conjugation, i.e. protein PEPylation, for improved pharmacological properties [ 43 , 51 , 54 , 57–61 ]. But the function of PLP for protein modification is yet to be fully exploited.…”
Section: Discussionmentioning
confidence: 99%
“…Synthetic polypeptides have been used for protein conjugation, i.e. protein PEPylation, for improved pharmacological properties [ 43 , 51 , 54 , 57–61 ]. But the function of PLP for protein modification is yet to be fully exploited.…”
Section: Discussionmentioning
confidence: 99%
“…8,39 Encouraged by the robustness of the ROP at various pH and salt concentrations (Figure S4&7), we further examined whether amine-bearing proteins could be utilized as macroinitiator to generate protein-PLP conjugates in situ (Figure 5A). [40][41][42][43][44][45][46][47] The protein-initiated ROP of various NCAs, including ProNCA, was previously tested in 1950-1960s but later discontinued. [48][49] Here, we decided to revisit this topic using the fast ROP in mixed ACN/H 2 O. Gratifyingly, 10-min ROP of ProNCA at 10 o C in ACN/PBS (v/v = 1/1, pH 7.4) in EGFP solution led to the efficient formation of EGFP-PLP conjugates based on SDS-PAGE analysis.…”
Section: Resultsmentioning
confidence: 99%
“…[114] Followed by this work, in 2021, Lu and co-workers produced IFN-PolyDox-PEP with IFN-PDS-PEP, a multifunctional and stimuliresponsive protein-drug-polymer (PDP), realizing the synergistic co-delivery of IFN and doxorubicin (Dox) (Scheme 14d). [115] These studies clearly demonstrate the strong potential of highly efficient chemistry to construct well-defined PEPylations which are promising and powerful macromolecules for various chemo-protein combination therapies. [116]…”
Section: Modification Of Other Species Of Side Chainsmentioning
confidence: 86%
“…Using this method, Lu's group prepared interferon (IFN) modified with the helical polypeptide, which displayed stronger binding affinity as well as higher antiproliferative activity and efficacy in vitro compared to IFN modified by PEG (Scheme 14d) [114] . Followed by this work, in 2021, Lu and co‐workers produced IFN‐PolyDox‐PEP with IFN‐PDS‐PEP, a multifunctional and stimuli‐responsive protein‐drug‐polymer (PDP), realizing the synergistic co‐delivery of IFN and doxorubicin (Dox) (Scheme 14d) [115] . These studies clearly demonstrate the strong potential of highly efficient chemistry to construct well‐defined PEPylations which are promising and powerful macromolecules for various chemo‐protein combination therapies [116] …”
Section: Post‐polymerization Reactions On Different Side‐chains Of Po...mentioning
confidence: 99%